{"id":"NCT02298192","sponsor":"Novo Nordisk A/S","briefTitle":"A Clinical Trial Comparing Efficacy and Safety of Insulin Degludec/Liraglutide (IDegLira) in Subjects With Type 2 Diabetes Mellitus Using Two Different Titration Algorithms","officialTitle":"A Clinical Trial Comparing Efficacy and Safety of Insulin Degludec/Liraglutide (IDegLira) in Subjects With Type 2 Diabetes Mellitus Using Two Different Titration Algorithms","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2014-11-21","primaryCompletion":"2015-12-23","completion":"2015-12-23","firstPosted":"2014-11-21","resultsPosted":"2017-05-23","lastUpdate":"2017-05-23"},"enrollment":420,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Diabetes","Diabetes Mellitus, Type 2"],"interventions":[{"type":"DRUG","name":"insulin degludec/liraglutide","otherNames":[]}],"arms":[{"label":"Once weekly titration","type":"EXPERIMENTAL"},{"label":"Twice weekly titration","type":"EXPERIMENTAL"}],"summary":"This trial is conducted in Europe, North America and the United States of America.\n\nThe aim of this trial is to compare two different titration algorithms of insulin degludec/liraglutide.","primaryOutcome":{"measure":"Change From Baseline in HbA1c","timeFrame":"Week 0, week 32","effectByArm":[{"arm":"IDegLira (1WT)","deltaMin":-2.01,"sd":1.09},{"arm":"IDegLira","deltaMin":-2.02,"sd":0.98}],"pValues":[{"comp":"OG000 vs OG001","p":"0.012"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":9},"locations":{"siteCount":84,"countries":["United States","Austria","Bulgaria","Canada","Czechia","Hungary","Russia","Serbia","Slovakia"]},"refs":{"pmids":["28124817"],"seeAlso":["http://novonordisk-trials.com"]},"adverseEventsSummary":{"seriousAny":{"events":7,"n":209},"commonTop":["Nasopharyngitis","Nausea"]}}